Pharmacology

A New Treatment for Type 2 Diabetes; The Problem of Chemotherapy for Oldest-Old Patients; Clarithromycin and Cardiovascular Events

Canagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, approved by the FDA, works differently from other diabetes drugs: It blocks the kidneys from reabsorbing glucose via SGLTs, increasing glucose excretion.


 

Recommended Reading

Neutrophilic Dermatoses in a Diabetic Patient: An Easily Misdiagnosed Uncommon Variant
Federal Practitioner
Evaluation of Vitamin D Supplementation in a Veteran Population
Federal Practitioner
Vitamin D Deficiency
Federal Practitioner
Is Bariatric Surgery the Cure for Diabetes?
Federal Practitioner
A Generation of Progress in Endocrinology, Especially Cardiovascular Endocrinology
Federal Practitioner
OnabotulinumtoxinA for Bladder Problems; Older Cancer Patients Not Getting Full Treatment; Vitamin B Reduces Diabetic Neuropathy
Federal Practitioner
Elderly Veteran With Diabetes and Foot and Ankle Swelling
Federal Practitioner
Diabetes Foot Care
Federal Practitioner
For Lower Risk of Diabetes, Don't Eat So Fast
Federal Practitioner
Strategies From Those Who've Been There; Audiovisual Resources for People With Diabetes; Beat the Heat
Federal Practitioner